| Literature DB >> 25294661 |
Luciane D Pinto1, Iracema N Barros2, Renata F Budaszewski1, Matheus N Weber1, Helena Mata1, Jéssica R Antunes1, Fabiana M Boabaid3, Angélica T B Wouters3, David Driemeier3, Paulo E Brandão2, Cláudio W Canal4.
Abstract
Characterization of canine coronavirus (CCoV) strains currently in circulation is essential for understanding viral evolution. The aim of this study was to determine the presence of pantropic CCoV type IIa in tissue samples from five puppies that died in Southern Brazil as a result of severe gastroenteritis. Reverse-transcriptase PCR was used to generate amplicons for sequence analysis. Phylogenetic analysis of the CCoV-IIa strains indicated that they were similar to those found in other countries, suggesting a common ancestor of these Brazilian isolates. This is the first report of pantropic CCoV-II in puppies from Latin America and our findings highlight that CCoV should be included as a differential diagnosis when dogs present with clinical signs and lesions typically seen with canine parvovirus infection.Entities:
Keywords: Canine coronavirus; Canine parvovirus; Dog; Pantropic; Sequencing
Mesh:
Substances:
Year: 2014 PMID: 25294661 PMCID: PMC7110447 DOI: 10.1016/j.tvjl.2014.09.006
Source DB: PubMed Journal: Vet J ISSN: 1090-0233 Impact factor: 2.688
Fig. 1Maximum likelihood (ML) tree showing the relationships between CCoV strains (JX442376, JX442377 and JX442378 identified in the present study) based on (A) a 332 base pair (bp) fragment of the M gene, (B) a 569 bp fragment from the 3′end region of the S gene and (C) a 938 bp fragment of the S gene (5′end plus 3′end combined dataset), using the TIM2+G model. Nodal support values (<0.7 posterior probability or <70% bootstrap not shown) are indicated for ML and Bayesian (BI) methods, respectively. (–) indicates values <70%, while (*) stands for different resolution in BI analysis.
Amino acid differences between Brazilian and reference samples for the CCoV M gene.
| Amino acid position | |||||||
|---|---|---|---|---|---|---|---|
| Samplesa | 123 | 127 | 187 | 212 | 223 | 243 | 246 |
| Ile | Lys | Tyr | Asp | ||||
| Ile | Ile | Tyr | Ser | Tyr | Asp | ||
| Ile | Ile | Tyr | Ser | Lys | Tyr | Asp | |
| Ile | Ile | Tyr | Ser | Lys | Tyr | Asp | |
| Ile | Tyr | Ser | |||||
| Ile | Tyr | Ser | |||||
| Ile | Tyr | Ser | Lys | ||||
| Ile | Tyr | Ser | Lys | ||||
| NC002306 FCoV-II (USA) | Tyr | Ser | |||||
| Recombitek | Ile | Tyr | Ser | Lys | |||
aGenBank accession numbers are shown with country of origin in parentheses. Recombitek is a commercial vaccine. Amino acid differences are highlighted in bold text. *Identified in the present study.
Amino acid differences between Brazilian and reference samples for the 5′ region of the CCoV S gene.
| Amino acid position | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Samplesa | 5 | 20 | 21 | 34 | 38 | 54 | 72 | 78 | 125 |
| Thr | Thr | Val | Ala | Glu | |||||
| Val | Thr | Pro | Tyr | Val | Ala | Gln | Asp | ||
| KC138236* (Brazil) | Val | Pro | Tyr | Val | Ala | Glu | Asp | ||
| KC138237* (Brazil) | Val | Thr | Thr | Pro | Tyr | Val | Glu | Asp | |
| KC138238* (Brazil) | Thr | Thr | Pro | Tyr | Ala | Glu | Asp | ||
| NC002306 FCoV-II (USA) | Val | Thr | Thr | Val | Ala | Asp | |||
aGenBank accession numbers are shown with country of origin in parentheses. Amino acid differences are highlighted in bold text. *Identified in the present study.